| Title : Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53 - Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
| Author(s) : Chiorean EG , Sanghani S , Schiel MA , Yu M , Burns M , Tong Y , Hinkle DT , Coleman N , Robb B , LeBlanc J , Clark R , Bufill J , Curie C , Loehrer PJ , Cardenes H |
| Ref : Cancer Chemother Pharmacol , 70 :25 , 2012 |
| Abstract : |
| PubMedSearch : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
| PubMedID: 22610353 |
| Title : Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53 - Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
| Author(s) : Chiorean EG , Sanghani S , Schiel MA , Yu M , Burns M , Tong Y , Hinkle DT , Coleman N , Robb B , LeBlanc J , Clark R , Bufill J , Curie C , Loehrer PJ , Cardenes H |
| Ref : Cancer Chemother Pharmacol , 70 :25 , 2012 |
| Abstract : |
| PubMedSearch : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
| PubMedID: 22610353 |
| Title : Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53 - Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
| Author(s) : Chiorean EG , Sanghani S , Schiel MA , Yu M , Burns M , Tong Y , Hinkle DT , Coleman N , Robb B , LeBlanc J , Clark R , Bufill J , Curie C , Loehrer PJ , Cardenes H |
| Ref : Cancer Chemother Pharmacol , 70 :25 , 2012 |
| Abstract : |
| PubMedSearch : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25 |
| PubMedID: 22610353 |